Literature DB >> 9481230

Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years.

L F Callahan1, T Pincus, J W Huston, R H Brooks, E P Nance, J J Kaye.   

Abstract

OBJECTIVE: To analyze various quantitative measures of inflammatory activity and joint damage, including articular, radiographic, laboratory, questionnaire, and physical function measures, in regard to changes in status in surviving patients and prediction of mortality in non-survivors over 5 years in a cohort of patients with rheumatoid arthritis (RA) monitored in the mid-1980s and early 1990s.
METHODS: A comprehensive evaluation, which included a complete joint count, radiograph, laboratory tests, physical measures of function, and self-report questionnaire scales, was performed at baseline and 5 years later in 210 consecutive patients with RA.
RESULTS: Five years after baseline, 206 of the 210 patients were accounted for: 37 had died, 130 had a comprehensive repeat assessment, and 39 had a more limited repeat assessment. In surviving patients, most measures of activity were generally unchanged or somewhat better, including joint tenderness, pain on motion, and swelling; erythrocyte sedimentation rate and rheumatoid factor; as well as questionnaire scores for pain, global status, helplessness, and difficulty in performing 8 activities of daily living (ADL) according to a modified Health Assessment Questionnaire (MHAQ). By contrast, measures of damage, including joint deformity, grip strength, walk time, and radiographic scores, indicated worse status. Mortality over 5 years was predicted significantly in univariable analyses by American College of Rheumatology (formerly the American Rheumatism Association) Functional Class, limited joint motion, scores for MHAQ, global status, helplessness, grip strength, walk time, button time, and number of comorbidities and duration of diseases, as well as the sociodemographic measures of age and formal education. In multivariable Cox regressions, age, comorbidities, MHAQ, and other measures of functional status were the most effective predictors of 5-year mortality.
CONCLUSION: In patients with RA, most measures of inflammatory activity were unchanged and sometimes better, while measures of damage indicated worse status in the same patients over 5 years. Measures indicating functional disability, as well as age and comorbidities, predict 5-year mortality more effectively than radiographic and laboratory data. Measures of inflammatory activity may underestimate long-term outcomes in RA, and long-term studies should include measures of damage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9481230     DOI: 10.1002/art.1790100606

Source DB:  PubMed          Journal:  Arthritis Care Res        ISSN: 0893-7524


  18 in total

Review 1.  Measuring hand grip strength in rheumatoid arthritis.

Authors:  Susie C Higgins; Jo Adams; Rodney Hughes
Journal:  Rheumatol Int       Date:  2018-04-06       Impact factor: 2.631

2.  Rheumatoid arthritis quality measures and radiographic progression.

Authors:  Sonali P Desai; Chih-Chin Liu; Heather Tory; Tabatha Norton; Michelle Frits; Siri Lillegraven; Michael Weinblatt; Jonathan Coblyn; Jinoos Yazdany; Nancy Shadick; Daniel H Solomon
Journal:  Semin Arthritis Rheum       Date:  2014-01-25       Impact factor: 5.532

Review 3.  Genetic influences on rheumatoid arthritis in African Americans.

Authors:  Laura B Hughes; Larry W Moreland; S Louis Bridges
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

4.  Patient-reported outcomes as predictors of remission in early rheumatoid arthritis patients treated with tight control treat-to-target approach.

Authors:  Laura Kuusalo; Kari Puolakka; Hannu Kautiainen; Anna Karjalainen; Timo Malmi; Timo Yli-Kerttula; Marjatta Leirisalo-Repo; Vappu Rantalaiho
Journal:  Rheumatol Int       Date:  2017-03-13       Impact factor: 2.631

5.  Declines in number of tender and swollen joints in patients with rheumatoid arthritis seen in standard care in 1985 versus 2001: possible considerations for revision of inclusion criteria for clinical trials.

Authors:  T Pincus; T Sokka; C P Chung; G Cawkwell
Journal:  Ann Rheum Dis       Date:  2005-12-08       Impact factor: 19.103

6.  Power Doppler sonography in the assessment of synovial tissue of the knee joint in rheumatoid arthritis: a preliminary experience.

Authors:  M Carotti; F Salaffi; P Manganelli; D Salera; B Simonetti; W Grassi
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

Review 7.  Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa?

Authors:  T Pincus; T Sokka
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

8.  Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis.

Authors:  Sigrid Odegård; Arnstein Finset; Petter Mowinckel; Tore K Kvien; Till Uhlig
Journal:  Ann Rheum Dis       Date:  2007-03-28       Impact factor: 19.103

9.  Relative responsiveness of physician/assessor-derived and patient-derived core set measures in rheumatoid arthritis trials.

Authors:  Tuhina Neogi; Hui Xie; David T Felson
Journal:  J Rheumatol       Date:  2008-04-15       Impact factor: 4.666

10.  Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial.

Authors:  T Pincus; C J Swearingen; G Luta; T Sokka
Journal:  Ann Rheum Dis       Date:  2008-12-15       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.